Alkermes plc Message Board

Don't you think though by announcing a reverse stock split of 1 to 70 or 1 to 200 spooked the investors despite good news on trials? Even with good news people are stepping aside because they don't want to go through a R/S and more dilution after uplist. Management has killed any momentum it could have gotten at ASCO.

Sentiment: Strong Sell

CTIX trades on OTC BB it has gone from .45 cents per share up to where it is now at $2.10 per share and never needed to uplist. If the management is sound and the science is good the OTC BB stock trading is not holding this back. That's for sure!

Sentiment: Strong Sell

Not only that but this company has a drug where you can see the efficacy in a phase 1 trial. other drug companies like HALO, GALE, CYCC you can't see efficacy until phase 2 trial is complete. This company when it un blinds data for phase 1 will be considered phase 2 results. Because we will see whether it reduces scarring or it doesn't.

Sentiment: Strong Buy

They are saying they are not sure if the Nasdaq capital market will accept their application but if it does they are moving forward with it.

We are offering shares of our common stock and warrants to purchase up to an aggregate of shares of our common stock. The warrants will have a per share exercise price of $ [[125%] of public offering price of the common stock]. The warrants are exercisable immediately and will expire [five] years from the date of issuance. We expect to effect a 1-for- reverse stock split of our issued and outstanding common stock prior to the date of this prospectus.
Our common stock is quoted on the Over-The-Counter Bulletin Board, or OTC Bulletin Board, under the symbol ADXS.OB. We have applied to list our common stock and warrants on The NASDAQ Capital Market under the symbols “ADXS” and “ADXSW,” respectively. No assurance can be given that our application will be approved. On May 14, 2013, the last reported sale price for our common stock on the OTC Bulletin Board was $0.05 per share.

Sentiment: Strong Sell

That is is amazing. What else is amazing is that drug RXI-109 continues to work 14 days after injection. That's a long time it still heals the wound even after so many days. Those results we see are just the single dose results. We haven't seen the multi dose results yet. if single dose obtains 51% reduction imagine how much percentage reduction multi dose gets. Could possibly be 80% or greater.

Sentiment: Strong Buy

Normally its on the website the same day after presentation. So either today or tomorrow I will inform if I see it today!

Sentiment: Strong Buy

yah let's buy so Chen can fork you in the #$%$ even more! LOL yah right. Whoever buys this turd should be embarrassed to be alive.

Sentiment: Strong Sell

Because the company guided down by $7 million dollars. Analysts expected $63 Million and RENN guided to $55 million. so instead of growing year over year at 47% they would grow next quarter only 20%. That's the bottom line of the downgrades and huge drop. it's a turd basically!

Sentiment: Strong Sell

bump for justice!

Sentiment: Strong Sell

Broadfin LLC, has a huge holding too around 30mil and OPKO health has 16% ownership of RXII. Big investment! Dr. Frost knows how to do his DD!!!

Should I listen to Dr. Frost who is a billionaire or all these #$%$ shorts who still live in their mom's basement? LOL

Sentiment: Strong Buy

Bump for the idiots who brought up the paid basher handbook with lies!

Sentiment: Strong Sell

so this is how you want to play ? fine lll bring back the PAID PUMPER HANDBOOK GUIDE TO LOSSES just for you!

Sentiment: Strong Sell

you are a complete idiot if you believe people are telling others to sell so they can buy. If you believe that nonsense you deserve to lose all of your money!

Sentiment: Strong Sell

Learn what? How to lose all of my life savings? ROFL!

Sentiment: Strong Sell

Totally agree! Paid pumpers would have you believe otherwise!

Sentiment: Strong Sell

I agree ralph!

Sentiment: Strong Sell

I'm not that dumb to invest in this turd! YOu might be!

Sentiment: Strong Sell

Analysts are normally tools, but sad to say this time they are right. Renn is a turd and the CEO knows it.

Sentiment: Strong Sell